Par R&D joint venture
Executive Summary
Par is providing financial assistance to TL Pharmaceutical Corp. for development of the company's drugs. In return, Par may choose TLPC products for sponsorship during the next five years and take share in profits from their sales during their entire market life. The Paramus, N.J.-based TLPC is developing drugs "with technologies that facilitate their ability to penetrate biological membranes including the blood-brain barrier," Par said.